Related references
Note: Only part of the references are listed.Emerging novel concept of chaperone therapies for protein misfolding diseases
Yoshiyuki Suzuki
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2014)
Abnormal pupillary light reflex with chromatic pupillometry in Gaucher disease
Aya Narita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
Ari Zimran et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice
Zhuo Luan et al.
BRAIN & DEVELOPMENT (2013)
Revised recommendations for the management of Gaucher disease in children
Paige Kaplan et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
Ying Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Discovery, Structure-Activity Relationship, and Biological Evaluation of Noninhibitory Small Molecule Chaperones of Glucocerebrosidase
Samarjit Patnaik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Clinical and genetic characteristics of Korean patients with Gaucher disease
Seon-Yong Jeong et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients
Ichraf Kraoua et al.
BRAIN & DEVELOPMENT (2011)
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)
P. Cherin et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison with N-(n-nonyl)-Deoxynojirimycin
Zhuo Luan et al.
CHEMBIOCHEM (2009)
Reassessment of phenytoin for treatment of late stage progressive myoclonus epilepsy complicated with status epilepticus
Ayako Miyahara et al.
EPILEPSY RESEARCH (2009)
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Randomized, Controlled Trial of Miglustat in Gaucher's Disease Type 3
Raphael Schiffmann et al.
ANNALS OF NEUROLOGY (2008)
Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III
J. Cox-Brinkman et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination
Jose L. Capablo et al.
EPILEPSIA (2007)
Enzyme enhancement activity of N-octyl-β-valienamine on β-glucosidase mutants associated with Gaucher disease
Ke Lei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death
S. Giri et al.
JOURNAL OF LIPID RESEARCH (2006)
N-octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells:: a potential chemical chaperone therapy for Gaucher disease
H Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Neuropathology provides clues to the pathophysiology of Gaucher disease
KD Wong et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Chemical chaperone therapy for brain pathology in GM1-gangliosidosis
J Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3
UH Schueler et al.
NEUROBIOLOGY OF DISEASE (2003)
Chemical chaperones increase the cellular activity of N370S β-glucosidase:: A therapeutic strategy for Gaucher disease
AR Sawkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype
E Orvisky et al.
MOLECULAR GENETICS AND METABOLISM (2002)
The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease
J Charrow et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
